Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis

…, L Bessette, C Flanagan, S LeClercq… - The Journal of …, 2012 - jrheum.org
Objective. To systematically identify and examine reports of sex-stratified pain measurements
in patients with inflammatory arthritis. Methods. Data sources included PubMed (1950 to …

Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials

…, S Jamal, J Karsh, T Landry, S Leclercq… - Arthritis care & …, 2016 - Wiley Online Library
Objective To assess the efficacy, tolerability, and safety of cannabinoids (phyto‐ and
syntheto‐) in the management of rheumatic diseases. Methods Multiple databases, including …

[HTML][HTML] Myeloablative autologous stem-cell transplantation for severe scleroderma

…, L Griffing, J Storek, S LeClercq… - … England Journal of …, 2018 - Mass Medical Soc
Background Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma)
often has a devastating outcome. We compared myeloablative CD34+ selected autologous …

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying …

…, B Haraoui, M Khraishi, SA LeClercq… - The Journal of …, 2012 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) has developed recommendations
for the pharmacological management of rheumatoid arthritis (RA) with traditional and …

Rapid responses to anakinra in patients with refractory adult‐onset Still's disease

AA Fitzgerald, SA LeClercq, A Yan… - Arthritis & …, 2005 - Wiley Online Library
Objective To assess the efficacy of anakinra treatment in patients with adult‐onset Still's
disease (AOSD) that is refractory to corticosteroids, methotrexate (MTX), and etanercept. …

The development of systemic sclerosis classification criteria

JG Walker, J Pope, M Baron, S LeClercq… - Clinical …, 2007 - Springer
Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains
obscure, although environmental and genetic influences are likely to play a role. Disease …

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled …

…, AW Wong, CD Fell, SA LeClercq… - The Lancet …, 2023 - thelancet.com
Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7·7%. We aimed to assess the safety…

Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying …

…, A Dooley, B Haraoui, M Khraishi, SA Leclercq… - The Journal of …, 2012 - jrheum.org
Objective. The Canadian Rheumatology Association (CRA) has developed recommendations
for the pharmacological management of rheumatoid arthritis (RA) with traditional and …

A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal …

…, GS Jhangri, AA Fitzgerald, S LeClercq… - Arthritis & …, 2002 - Wiley Online Library
Objective To determine the safety and efficacy of intravenous (IV) pamidronate treatment in
ankylosing spondylitis (AS) patients who have had a suboptimal response to nonsteroidal …

Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

…, R Lambert, GS Jhangri, S Leclercq… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To examine the potential therapeutic properties of an aminobisphosphonate,
pamidronate, using clinical and laboratory outcome variables together with dynamic magnetic …